Prognosis of segmentectomy in the treatment of stage IA non-small cell lung cancer
- PMID: 33365085
- PMCID: PMC7716705
- DOI: 10.3892/ol.2020.12335
Prognosis of segmentectomy in the treatment of stage IA non-small cell lung cancer
Abstract
With improvements in detection technology, increasing numbers of patients with non-small cell lung cancer (NSCLC) are being diagnosed at an early stage. In order to treat the illness with minimal invasion and preserve lung function to the greatest possible extent, there has been an increasing tendency towards treating early-stage NSCLC by segmentectomy. However, questions remain regarding whether patients may benefit from this procedure considering the surgical and oncological outcomes. Whether adequate margin distance and lymph node dissection may be achieved is one of the most important issues associated with this procedure. The present study reviews the prognosis of segmentectomy in the treatment of stage IA NSCLC.
Keywords: lobectomy; non-small cell lung cancer; segmentectomy.
Copyright: © Bai et al.
References
-
- National Lung Screening Trial Research Team. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409. doi: 10.1056/NEJMoa1102873. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources